MedTrace Logo

Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique

NCT04442165 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6049

Last updated 2025-03-06

Study results available
· View outcomes & findings →

Summary

A population-based COVID19 surveillance in a household cohort will be set-up using an existing Household demographic surveillance system (HDSS). From any individual in this population with any respiratory symptom or loss of smell or taste, with or without fever, investigators will collect a respiratory specimen and test these for SARS-CoV-2 virus, during 12 months. Demographic, epidemiological and clinical data of possible cases and of the source population will be recorded at baseline.

An age-stratified serial sero-survey will be conducted at baseline in a subset of the population in the population-based COVID19 surveillance, and at 3, 6 and 12 months, after confirmation of community transmission.

Conditions

Sponsors & Collaborators

  • European and Developing Countries Clinical Trials Partnership (EDCTP)

    collaborator OTHER_GOV

  • Instituto Nacional de Saúde, Mozambique

    collaborator OTHER_GOV

  • Institut de Recherche pour le Developpement

    collaborator OTHER_GOV

  • UMC Utrecht

    collaborator OTHER

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Marc-Alain Widdowson, Dr · Institute of Tropical Medicine

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2022-03-29
Completion
2022-03-29

Countries

  • Mozambique

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04442165 on ClinicalTrials.gov